| CAS No. | 149503-79-7 |
|---|---|
| MDL No. | N/A |
| MF | C23H25N3O6 |
| MW | 439.50 |
| InChI Key | PGCFXITVMNNKON-ROUUACIJSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | To Be Confirmed | $258 | In Stock | |
| 5 mg | To Be Confirmed | $622 | In Stock | |
| 10 mg | To Be Confirmed | $870 | In Stock | |
| 25 mg | To Be Confirmed | $1292 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Lefradafiban is a pyrrolidin-2-one with the 3-pro-S-hydrogen substituted by a 2-methoxy-2-oxoethyl group and the 5-pro-S-hydrogen substituted by a ({4'-[N-(methoxycarbonyl)carbamimidoyl]biphenyl-4-yl}oxy)methyl group. It is an orally active prodrug of fradafiban, a fibrinogen receptor antagonist, and functions as a platelet glycoprotein-IIb/IIIa receptor antagonist. It is a methyl ester and a member of pyrrolidin-2-ones, and is functionally related to fradafiban.
| CAS No. | 149503-79-7 |
|---|---|
| Product Name | Lefradafiban |
| Heavy Atom Count | 32 | Rotatable Bond Count | 7 |
| Atom Stereo Count | 2 | Bond Stereo Count | 1 |
| HBA | 6 | HBD | 2 |
| TPSA | 129.310 Ų | Charge | 0 |
| Exact Mass | 439.17434 | Complexity | 1001.40 |
| pKa | 7.130 | XLogP | 2.272 |
